Cargando…
Repeated Measurement of FIB-4 to Predict Long-Term Risk of HCC Development Up to 10 Years After SVR
PURPOSE: It is unclear whether and how the long-term risk of hepatocellular carcinoma (HCC) will change in hepatitis C virus (HCV) infected patients who have reached sustained virologic response (SVR) with direct-acting antivirals (DAA). In this study, we assessed the long-term risk of HCC up to 10...
Autores principales: | Zou, Yanzheng, Yue, Ming, Jia, Linna, Wang, Yidi, Chen, Hongbo, Wang, Yifan, Zhang, Meiling, Feng, Yue, Yu, Rongbin, Yang, Sheng, Huang, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809166/ https://www.ncbi.nlm.nih.gov/pubmed/36606114 http://dx.doi.org/10.2147/JHC.S389874 |
Ejemplares similares
-
Accurate prediction of HCC risk after SVR in patients with hepatitis C cirrhosis based on longitudinal data
por: Zou, Yanzheng, et al.
Publicado: (2023) -
Dynamics of APRI and FIB-4 in HCV cirrhotic patients who achieved SVR after DAA therapy
por: Leuştean, Anca, et al.
Publicado: (2021) -
Concordance of SVR12, SVR24 and SVR durability in Taiwanese chronic hepatitis C patients with direct-acting antivirals
por: Lin, Chuan-Pin, et al.
Publicado: (2021) -
1069. Loss to follow-up does not impact SVR for HCV infection
por: Kottilil, Sita K, et al.
Publicado: (2020) -
FIB nanostructures
por: Wang, Zhiming M
Publicado: (2013)